Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CDMO | US
0.18
1.74%
Healthcare
Biotechnology
30/04/2024
30/08/2024
10.54
10.51
10.57
10.17
Avid Bioservices Inc. a contract development and manufacturing organization provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services of biologics for the biotechnology and biopharmaceutical industries. The company offers various services including clinical and commercial drug substance manufacturing bulk packaging release and stability testing and regulatory submission and support. It also provides various process development services such as upstream and downstream development and optimization analytical methods development cell line development testing and characterization. The company was formerly known as Peregrine Pharmaceuticals Inc. and changed its name to Avid Bioservices Inc. in January 2018. Avid Bioservices Inc. was incorporated in 1981 and is headquartered in Tustin California.
View LessPrice Below SMA10D
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
49.4%1 month
41.3%3 months
73.7%6 months
80.2%-
88.50
11.04
3.41
0.62
107.87
6.01
-
-7.57M
670.14M
670.14M
-
-3.01
-79.70
8.00
-112.58
10.79
24.15
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.50
Range1M
1.86
Range3M
5.04
Rel. volume
0.74
Price X volume
5.55M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Corbus Pharmaceuticals Holdings Inc | CRBP | Biotechnology | 61.18 | 736.85M | 5.46% | n/a | 11.79% |
ORIC Pharmaceuticals Inc | ORIC | Biotechnology | 10.37 | 731.53M | 1.67% | n/a | 0.92% |
Arbutus Biopharma Corporation | ABUS | Biotechnology | 3.87 | 730.59M | 1.04% | n/a | 6.09% |
iShares $ Corp Bond ETF USD Dist | LQDA | Biotechnology | 9.51 | 730.31M | -0.31% | n/a | 4.70% |
Applied Therapeutics Inc | APLT | Biotechnology | 6.34 | 728.12M | 4.28% | n/a | 0.30% |
Travere Therapeutics Inc. | TVTX | Biotechnology | 9.47 | 724.37M | 1.18% | n/a | 2662.08% |
Humacyte Inc | HUMA | Biotechnology | 6.05 | 722.07M | -1.63% | n/a | -63.37% |
Mereo BioPharma Group plc | MREO | Biotechnology | 4.69 | 721.57M | 2.40% | n/a | 7.83% |
Wave Life Sciences Ltd | WVE | Biotechnology | 5.74 | 716.00M | 0.53% | n/a | 656.70% |
NRXPW | NRXPW | Biotechnology | 0.0601 | 715.80M | -33.22% | n/a | -46.73% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Latham Group Inc. | SWIM | Building Products & Equipment | 6.25 | 722.36M | 0.32% | 56.82 | 77.00% |
Ennis Inc | EBF | Building Products & Equipment | 23.91 | 621.28M | 1.18% | 14.94 | 2.42% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.48 | 524.97M | 0.55% | n/a | 174.23% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 12.45 | 391.86M | -0.16% | 49.80 | 88.92% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 24.03 | 385.84M | 0.33% | n/a | 286.96% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.4 | 326.35M | 0.00% | 12.70 | 0.00% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 28.64 | 316.93M | -0.52% | 18.84 | -621.78% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 18.53 | 314.66M | -0.70% | 36.33 | 26.79% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 15.53 | 251.70M | 1.70% | 9.96 | 15.44% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 53.7 | 152.52M | -0.37% | 8.42 | 71.47% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 107.87 | 0.97 | Expensive |
Ent. to Revenue | 6.01 | 3,681.29 | Cheaper |
PE Ratio | - | 39.83 | - |
Price to Book | 11.04 | 14.54 | Cheaper |
Dividend Yield | - | 2.19 | - |
Std. Deviation (3M) | 73.67 | 76.13 | Par |
Debt to Equity | 3.41 | -2.05 | Expensive |
Debt to Assets | 0.62 | 0.25 | Expensive |
Market Cap | 670.14M | 4.04B | Emerging |